Product correctly added to cart.

discount label
Notoginsenoside R4
View 3D

Biosynth logo

Notoginsenoside R4

CAS: 87741-77-3

Ref. 3D-MDA74177

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 20 Aug 2024

Product Information

Name:
Notoginsenoside R4
Description:

Notoginsenoside R4 is a potent compound that has been found to have antitumor properties. It is an analog of glimepiride, which is a kinase inhibitor used in the treatment of diabetes. Notoginsenoside R4 has been shown to inhibit the growth of cancer cells and induce apoptosis in tumor cells. This compound has also been found in urine samples from Chinese subjects, indicating its potential as a biomarker for cancer diagnosis. Studies have shown that notoginsenoside R4 can inhibit the activity of kinases such as apomorphine and nintedanib, which are involved in cancer cell growth and proliferation. This makes it a promising candidate for the development of new cancer therapies and inhibitors.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
1,241.4 g/mol
Formula:
C59H100O27
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-MDA74177 Notoginsenoside R4

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".